Lindsay Androski
Known title: President and CEOCIK: 0001936604
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Eloxx Pharmaceuticals Included in Pre-Market Movers List. Eloxx Pharmaceuticals was featured in a recent roundup of healthcare stocks showing movement during Monday's pre-market session. The company currently trades with a low trailing P/E ratio of 5.3, which is significantly below the average analyst target price of $38.25. This inclusion highlights current market attention on the stock, though the specific drivers for the pre-market activity are not detailed in the provided report.
Transaction History
| ABUS | ▼ Sell | Other | 24,655 | $123K | 10/1/2026 | View on chart |
| ABUS | ▲ Buy | Option Exercise | 116,408 | $373K | 9/18/2026 | View on chart |
| ABUS | ▲ Buy | Option Exercise | 10,456 | $46K | 9/18/2026 | View on chart |
| ABUS | ▼ Sell | Tax Withholding | 82,527 | $418K | 9/18/2026 | View on chart |
| ABUS | ▲ Buy | Grant | 28,000 | $0 | 2/2/2026 | View on chart |
| ELOX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/24/2025 | View on chart |
| ELOX | ▲ Buy | Grant | 12,000 | $0 | 10/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
ABUS Featured in Whale Alert List of 10 Health Care Stocks
Arbutus Biopharma (ABUS) was named in a Benzinga article that highlighted 10 health care stocks receiving whale alerts during the day. The mention suggests that large institutional traders have placed sizable orders in ABUS. The stock is currently near its $4.26 support level, with an RSI of 40.4 and recent volume spikes. This activity may signal increased market interest in ABUS.
ABUS Featured in Whale Alert List of 10 Health Care Stocks. Arbutus Biopharma (ABUS) was named in a Benzinga article that highlighted 10 health care stocks receiving whale alerts during the day. The mention suggests that large institutional traders have placed sizable orders in ABUS. The stock is currently near its $4.26 support level, with an RSI of 40.4 and recent volume spikes. This activity may signal increased market interest in ABUS.